Woolcock Institute of Medical Research
- Country
- 🇦🇺Australia
- Ownership
- Private
- Established
- 1981-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.woolcock.org.au
Clinical Trials
83
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (72 trials with phase data)• Click on a phase to view related trials
A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults with Insomnia.
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Woolcock Institute of Medical Research
- Target Recruit Count
- 20
- Registration Number
- NCT06823752
- Locations
- 🇦🇺
Woolcock Institute of Medical Research, Macquarie Park, New South Wales, Australia
A Novel Inhaled Formulation of Melatonin to Treat Adults with Insomnia: Pharmacokinetic Study
- Conditions
- Insomnia
- Interventions
- Drug: Inhaled Melatonin (100 μg)Drug: Oral Melatonin (4 mg)
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Woolcock Institute of Medical Research
- Target Recruit Count
- 5
- Registration Number
- NCT06801379
- Locations
- 🇦🇺
Woolcock Institute of Medical Research, Macquarie Park, New South Wales, Australia
A Novel Inhaled Formulation of Melatonin to Treat Adults with Insomnia: Efficacy Study
- Conditions
- Insomnia
- Interventions
- Drug: Inhaled Melatonin (100 μg)Drug: Oral Melatonin (4 mg)
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Woolcock Institute of Medical Research
- Target Recruit Count
- 10
- Registration Number
- NCT06802913
- Locations
- 🇦🇺
Woolcock Institute of Medical Research, Macquarie Park, New South Wales, Australia
The Feasibility of Overnight Time Restricted Eating and Impact on Glucose Levels in Shift Workers
- Conditions
- Shift WorkEating Behaviors
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- Woolcock Institute of Medical Research
- Target Recruit Count
- 30
- Registration Number
- NCT06686667
- Locations
- 🇦🇺
The Sutherland Hospital, Caringbah, New South Wales, Australia
The Effects of Insomnia Treatment on Overnight Regulation of Emotional Memories and Risk for Mental Disorders
- Conditions
- Depression, AnxietyInsomnia Chronic
- First Posted Date
- 2024-08-22
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Woolcock Institute of Medical Research
- Target Recruit Count
- 110
- Registration Number
- NCT06567210
- Locations
- 🇦🇺
Woolcock Institute of Medical Research, Macquarie Park, New South Wales, Australia
- Prev
- 1
- 2
- 3
- Next
News
Levofloxacin Shows Promise in Preventing Multidrug-Resistant Tuberculosis
A clinical trial in Vietnam demonstrated that a six-month course of daily levofloxacin significantly reduced the risk of developing multidrug-resistant tuberculosis (MDR-TB).